Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
life sciences
national blog main
national top stories
new york blog main
new york top stories
6
×
san francisco blog main
biotech
boston top stories
fda
san francisco top stories
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
indiana blog main
indiana top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
clinical trials
ipo
national
startups
vc
cancer
chronic kidney disease
crispr
digital health
flagship pioneering
glaxosmithkline
medical devices
messenger rna
What
therapeutics
6
×
new
bio
companies
drug
field
immunotherapy
ipo
latest
life
medicines
million
momentum
roundup
science
week
agency
aimmune
aims
allergy
allogene
announced
approach
approval
approved
awarded
backs
based
bets
biotech
biotechs
black
called
cancer
click
club
continue
continued
crispr
crop
Language
unset
Current search:
xconomy.com
×
therapeutics
×
" new york top stories "
×
@xconomy.com
4 years ago
Aimmune Awarded First FDA Approval for a Peanut Allergy Therapy
@xconomy.com
4 years ago
Bio Roundup: Mammoth Moves, Black Diamond’s Pop, Ohana’s Debut & More
@xconomy.com
4 years ago
Flagship’s Omega Aims to Take Epigenetic Drugs a Step Further
@xconomy.com
5 years ago
Bio Roundup: BIO Diversity, Allogene IPO, CRISPR In Utero & More
@xconomy.com
5 years ago
Sanofi Backs Click Therapeutics as Digital Medicines Gain Momentum
@xconomy.com
5 years ago
IPO Wave Rolls On as Five Life Science Firms Haul in $651M